Design and pre-clinical evaluation of a universal HIV-1 vaccineImmunoinformatics comes of ageHIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBECA new classification for HIV-1Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodiesHIV-Host Interactions: Implications for Vaccine DesignHuman Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus MacaquesA jumping profile Hidden Markov Model and applications to recombination sites in HIV and HCV genomesMaturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic AntibodyTrimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and GTiming the ancestor of the HIV-1 pandemic strainsTracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutininElucidation of hepatitis C virus transmission and early diversification by single genome sequencingThe evolutionary rate dynamically tracks changes in HIV-1 epidemics: application of a simple method for optimizing the evolutionary rate in phylogenetic trees with longitudinal dataAutologous neutralizing antibodies to the transmitted/founder viruses emerge late after simian immunodeficiency virus SIVmac251 infection of rhesus monkeysEpigraph: A Vaccine Design Tool Applied to an HIV Therapeutic Vaccine and a Pan-Filovirus VaccineIdentification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infectionFitness costs of rifampicin resistance in Mycobacterium tuberculosis are amplified under conditions of nutrient starvation and compensated by mutation in the β' subunit of RNA polymeraseUsing human immunodeficiency virus type 1 sequences to infer historical features of the acquired immune deficiency syndrome epidemic and human immunodeficiency virus evolutionEvolutionary and immunological implications of contemporary HIV-1 variation.Characterization and comparison of recombinant simian immunodeficiency virus from drill (Mandrillus leucophaeus) and mandrill (Mandrillus sphinx) isolates.The role of recombination in the emergence of a complex and dynamic HIV epidemic.A computational framework for the analysis of peptide microarray antibody binding data with application to HIV vaccine profilingEvidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo.Envelope vaccination shapes viral envelope evolution following simian immunodeficiency virus infection in rhesus monkeys.High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men.Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman PrimatesTiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies.Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variablesAntigenicity-defined conformations of an extremely neutralization-resistant HIV-1 envelope spike.HIV-1 vaccine development after STEP.Detection of HIV-1 p24 Gag in plasma by a nanoparticle-based bio-barcode-amplification method.Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing.Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection.Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys.Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys.Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies.Estimating time since infection in early homogeneous HIV-1 samples using a poisson model.Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels.
P50
Q21092234-270FDEEA-7D34-441A-AED7-77EA79B2FDFDQ21145682-446AEF68-0A80-47DF-8C66-92A098F23007Q21559422-4D64195E-F2C3-4236-93F3-CFA8326A91EFQ22251292-BB266FE6-654D-4DBE-80E2-F096FEDC3C69Q24561905-772E3634-63DF-4B05-A780-4EB73E72B868Q26765966-CA955C8E-91CE-41F9-A738-E4C69225C3CDQ27318508-BEC32897-C65C-43DF-BA18-FB208FBA3863Q27473421-6A0EBD0F-1A55-4281-8E1D-0308BE0E9B3EQ27644415-404FC718-E206-457F-9F6E-18EFFAC2944EQ27704710-032320E8-06FC-4577-95D6-3A852ABD4A99Q28137904-8B7B5D45-71ED-4C34-ADA2-7D76A7138B98Q28264707-F785E0A3-C481-4D29-84F3-26E298B1BFC5Q28482493-755F062E-0666-4FC3-89EC-C83F1A27268CQ28742086-1F52A62C-A3CB-4648-8988-09F304C600A5Q28751926-1B8E4190-60AB-4EEE-99E4-1EB350AEA098Q28822525-70A84128-2479-485A-AB2F-3DF9C931E6CDQ29619510-6C49CE63-90F4-4264-B9DB-CF51764CBB02Q30153449-991A0E81-6DC2-4F33-9EE2-8336BE20B112Q30328299-FB0F8556-6F08-463A-B88A-60EB414C837DQ30329205-FA62C15B-9B27-4F1D-A884-FC389AE1ADA3Q30332664-075BF23D-F8BC-4A7F-9601-E5D51DBFEBD6Q30387214-2D63873C-F99B-4B55-B75A-406B53C6F151Q30648718-7CC3B690-8A4B-42BE-8E7D-BE234227CA5FQ33290217-9724FCCC-023F-43B8-BDFD-C8DB3093F07BQ33455862-3EE28D54-1995-4E64-841C-0F0B197F7C78Q33558407-7D05507C-E2CB-4108-A29A-0239BA7FEE81Q33582135-321B1629-4746-42FE-958A-859435035E51Q33612459-4081F04F-7D9A-41AE-BD0D-C6596AED3C9BQ33614365-7C3AE301-2629-47F1-8FC4-A2EAB859421CQ33614495-4C350851-83D5-488B-BB3C-9D462EC46285Q33620194-F6354091-4984-48C9-88B8-5022FBFB53EAQ33642318-4F2F888B-B361-45E7-8CDF-DCB3C6E8B850Q33652072-6CE44748-C239-4D4E-A7BB-9F447855F1FDQ33680395-1D534DA1-C511-4C8A-9FA6-BE55CCF29332Q33702217-B085CE81-830D-4F5F-987D-A9B9584BAC4BQ33712291-B2BDA321-475A-426A-A880-E9CA65469AF8Q33712578-B3DA7F04-6283-4393-9B44-658D9DB16A2DQ33719511-F7D7DB2D-E294-4598-96AD-56BC7A285197Q33727328-BEE59846-0A70-4353-9C34-6647F2D8482AQ33780649-462F63D5-9E4B-4A94-A5DF-A7BF8DF56775
P50
description
computational biologist
@en
name
Bette Korber
@ast
Bette Korber
@en
Bette Korber
@es
Bette Korber
@fr
Bette Korber
@nl
Bette Korber
@sl
بيت كوربير
@ar
type
label
Bette Korber
@ast
Bette Korber
@en
Bette Korber
@es
Bette Korber
@fr
Bette Korber
@nl
Bette Korber
@sl
بيت كوربير
@ar
prefLabel
Bette Korber
@ast
Bette Korber
@en
Bette Korber
@es
Bette Korber
@fr
Bette Korber
@nl
Bette Korber
@sl
بيت كوربير
@ar
P1153
19335057200
P21
P2456
P31
P496
0000-0002-2026-5757
P569
1950-01-01T00:00:00Z